Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme.
Beyond-FRONTIER: Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme
Sponsor: Asthma + Lung UK
This observational or N/A phase trial investigates COPD and Emphysema and is currently actively recruiting participants. Asthma + Lung UK leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Jun 2025 — Present [monthly]
Not Yet Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Asthma + Lung UK
- Chiesi UK
- Hull University Teaching Hospitals NHS Trust
- TidalSense
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.